Caucus explores crucial role of NIH research funding

John Howser
December 3, 2015

James Crowe Jr., M.D., director of the Vanderbilt Vaccine Center, and Anthony Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), recently participated in a U.S. Senate National Institutes of Health (NIH) caucus briefing held in Washington, D.C., by Senate NIH caucus co-chairs Sens. Lindsey Graham (R-SC) and Dick Durbin (D-IL).

Ebola survivors team with researchers to fight deadly virus

November 4, 2015

Recently, two Ebola survivors from Nigeria flew to Vanderbilt, not only to share their story of survival, but to provide blood samples for ongoing research in the Vanderbilt Medical Center. Researchers at Vanderbilt are developing antibodies that could help treat people infected with Ebola and protect people at high risk of infection.

Survivors of Ebola outbreak take part in VUMC vaccine study

September 24, 2015

Two survivors of a 2014 Ebola outbreak in Nigeria visited Vanderbilt University Medical Center last week to share their experiences and participate in a study aimed at finding ways to treat the often-fatal infection. The survivors are physicians at the First Consultants Medical Center in Lagos, where a Liberian man infected with the Ebola virus was admitted in July 2014. Eleven doctors and other hospital staff who came in contact with the man became infected, and four of them later died.

Ebola symposium to feature Nigerian physicians

September 10, 2015

Three Nigerian physicians who survived Ebola virus disease in July 2014 after coming in direct contact with an Ebola-infected patient will speak at Vanderbilt University Medical Center next Wednesday, Sept. 16. Benjamin Ohiaeri, M.D., founder and chief medical director of First Consultants Medical Center in Lagos, Nigeria, will join Ebola survivors Ada Igonoh, MBBS, Morris Ibeawuchi, MBBS, and Ige Adewale Adejoro, MBBS, to discuss how the hospital contained the spread of the deadly virus.

VUMC joins Human Vaccine Project as first scientific hub

July 16, 2015

Vanderbilt University Medical Center (VUMC), the Human Vaccines Project and the International AIDS Vaccine Initiative (IAVI) announced this week that VUMC has become the project’s first scientific hub. Incubated by IAVI, the Human Vaccines Project is a new public-private partnership that brings together leading academic research centers, industry, governments and nonprofits to accelerate the development of vaccines and immunotherapies against infectious diseases and cancers by decoding the human immune system.

KC Kids May Help in Finding Treatment for Enterovirus

July 13, 2015

KANSAS CITY, Mo. — A virus that hospitalized hundreds of area kids last summer and fall could return again this year or in years to come. Kansas City kids who’ve had enterovirus 68 may help in finding a way to prevent or treat the illness. More than 500 kids were hospitalized at Children’s Mercy Hospital last year with the virus. Dozens were in intensive care with severe breathing trouble. The virus was also linked to paralysis in a small number of kids.

Taos students seek local residents exposed to Hantavirus

July 13, 2015

A group of Taos area students is helping researchers at Vanderbilt University with a bit of medical detective work this summer: tracking down Hantavirus survivors in Northern New Mexico. A severe respiratory illness that can be deadly, Hantavirus directly effects more people in New Mexico than any other state in the U.S. One woman in Taos County was diagnosed with the disease this year.